Imperva Inc (IMPV) PT Set at $56.00 by Evercore ISI
Imperva Inc (NYSE:IMPV) has been given a $56.00 target price by analysts at Evercore ISI in a note issued to investors on Thursday. The brokerage presently has a “buy” rating on the software maker’s stock. Evercore ISI’s price target indicates a potential upside of 25.14% from the company’s previous close.
IMPV has been the topic of several other research reports. Zacks Investment Research raised Imperva from a “hold” rating to a “strong-buy” rating and set a $52.00 target price on the stock in a research note on Wednesday, August 2nd. BidaskClub raised Imperva from a “sell” rating to a “hold” rating in a research note on Tuesday, August 22nd. Wells Fargo & Co lowered Imperva from an “outperform” rating to a “market perform” rating in a research note on Monday, October 9th. Piper Jaffray Companies set a $58.00 target price on Imperva and gave the stock a “buy” rating in a research note on Monday, August 28th. Finally, Monness Crespi & Hardt increased their target price on Imperva from $55.00 to $57.00 and gave the stock a “buy” rating in a research note on Friday, July 28th. One equities research analyst has rated the stock with a sell rating, ten have issued a hold rating and eleven have issued a buy rating to the stock. The stock currently has a consensus rating of “Hold” and a consensus target price of $50.97.
Shares of Imperva (NYSE IMPV) opened at 44.75 on Thursday. The stock’s 50 day moving average price is $43.78 and its 200 day moving average price is $45.86. Imperva has a 52-week low of $34.40 and a 52-week high of $52.40. The company’s market capitalization is $1.51 billion.
Imperva (NYSE:IMPV) last posted its earnings results on Thursday, July 27th. The software maker reported ($0.10) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of $0.05 by ($0.15). Imperva had a negative return on equity of 5.00% and a negative net margin of 4.69%. The firm had revenue of $74.44 million for the quarter, compared to analyst estimates of $74.30 million. During the same period in the previous year, the company posted ($0.23) EPS. Imperva’s revenue was up 28.6% on a year-over-year basis. On average, equities research analysts forecast that Imperva will post $0.81 earnings per share for the current fiscal year.
In other news, Director Anthony J. Bettencourt sold 99,598 shares of the firm’s stock in a transaction dated Thursday, August 24th. The stock was sold at an average price of $43.59, for a total transaction of $4,341,476.82. Following the sale, the director now owns 99,598 shares of the company’s stock, valued at approximately $4,341,476.82. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 2.20% of the stock is currently owned by company insiders.
Hedge funds and other institutional investors have recently modified their holdings of the company. Wells Fargo & Company MN raised its position in shares of Imperva by 86.5% during the 2nd quarter. Wells Fargo & Company MN now owns 191,212 shares of the software maker’s stock worth $9,149,000 after acquiring an additional 88,701 shares in the last quarter. Capital Fund Management S.A. raised its position in shares of Imperva by 85.6% during the 2nd quarter. Capital Fund Management S.A. now owns 113,951 shares of the software maker’s stock worth $5,453,000 after acquiring an additional 52,559 shares in the last quarter. Bank of Nova Scotia acquired a new stake in shares of Imperva during the 1st quarter worth about $7,184,000. Eagle Asset Management Inc. raised its position in shares of Imperva by 17.7% during the 2nd quarter. Eagle Asset Management Inc. now owns 1,279,848 shares of the software maker’s stock worth $61,240,000 after acquiring an additional 192,625 shares in the last quarter. Finally, Balyasny Asset Management LLC acquired a new stake in shares of Imperva during the 2nd quarter worth about $5,563,000. 92.72% of the stock is currently owned by institutional investors and hedge funds.
Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company is engaged in the development, marketing, sales, service and support of cyber-security solutions. The Company’s products include its Imperva SecureSphere Paltform, Imperva CounterBreach and Imperva Camouflage for enterprise data centers, and Imperva Incapsula offering for cloud-based security services.
Receive News & Ratings for Imperva Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc and related companies with MarketBeat.com's FREE daily email newsletter.